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Abstract 
MicroRNAs (miRNAs) comprise a large family of small ~21nt nucleotide long 
endogenous, single-stranded noncoding RNAs that regulate gene expression. The 
biogenesis of miRNAs is mediated by the two RNase III-like enzymes Drosha and 
Dicer. Fully grown Xenopus oocytes are transcriptionally inactive and arrested at 
meiotic prophase I. Maturation to eggs by progesterone allows progression of the 
oocytes into meiosis II leading to germinal vesicle breakdown (GVBD) accompanied 
by a complex network of regulation of stored maternal RNAs. 
In order to gain insight in the regulation of miRNA biogenesis during Xenopus 
oogenesis we performed miRNA precursor microinjection experiments in oocytes and 
eggs. We were able to show the activation of pri-miRNA processing and the 
enhancement of endogenous miRNA expression upon maturation to eggs. 
Consequently, tests on the developmental regulation of Drosha enzyme were 
performed, suggesting that Drosha is neither transcriptionally activated nor post-
translationally inactivated upon maturation. 
Further, the effects of RNA editing, a post-transcriptional single nucleotide 
modification, on miRNA processing were studied in Xenopus eggs. Microinjection 
experiments indicate an important role for RNA editing in blocking pri-miRNA 
processing in vivo. 
Zusammenfassung 
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Zusammenfassung 
Die Familie der mikroRNAs (miRNAs) spielt eine wichtige Rolle bei der post-
transkriptionellen Genregulation. Sie besteht aus kleinen ~21 Nukleotid-langen 
endogenen, einzelsträngigen, nicht-kodierenden RNA Molekülen. Die Biogenese von 
miRNAs wird von den beiden RNase III-Enzymen Drosha und Dicer reguliert. 
Ausgewachsene Xenopus Oozyten sind transkriptionell inaktiv und arretieren in der 
meiotischen Prophase I. Maturation mittels des Hormons Progesteron führt die 
Oozyten weiter in die Meiose II, was zum Zusammenbruch der zellulären 
Kernstruktur und der Aktivierung eines komplexen Regulationsnetzwerks von 
maternal gespeicherten RNA Molekülen führt. 
Um die Regulierung der Reifung von miRNA-Molekülen während der Entwicklung 
von Oozyten zu Eiern zu untersuchen wurde ein Mikroinjektionssystem von miRNA-
Vorläuferstufen etabliert. Wir konnten eine Aktivierung der Prozessierung von 
primären miRNA-Transkripten (pri-miRNA) sowie eine Erhöhung der Expression 
endogener miRNAs nachweisen. Weitere Experimente zur Untersuchung der 
Regulation des Enzyms Drosha während der Maturation zu Eiern konnten zeigen, 
dass dieses weder transkriptionell noch post-translational reguliert wird. 
Weitere Studien zum Effekt von RNA-Editierung, einer post-transkriptionellen 
Einzelnukleotid-Modifikation, auf die Prozessierung von miRNAs wurden in Xenopus 
Eiern durchgeführt. Mikroinjektionsexperimente konnten eine wichtige Rolle der 
RNA-Editierung bei der Hemmung der Prozessierung von pri-miRNAs in vivo 
belegen. 
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Introduction 
RNA interference (RNAi) 
RNA interference (RNAi) is a post-transcriptional gene silencing mechanism that 
regulates gene expression in animals and plants by the formation of double-stranded 
RNA (dsRNA). The first evidence that RNAi is mediated by dsRNA came from 
injection experiments in Caenorhabditis elegans (Fire et al., 1998). Initially, the 
phenomenon of post-transcriptional gene silencing (PTGS) was described in plants 
and quelling fungi (Jorgensen, 1990, Romano and Macino, 1992). Further, the 
sequence specific effector molecules of RNAi were identified as short RNA species 
(21-25nt) in plants undergoing PTGS (Hamilton and Baulcombe, 1999). 
During RNAi, dsRNA (produced by transgenes, viruses, repeat elements, supplied by 
microinjection, transfection, etc.) is processed to ~21nt small interfering RNAs 
(siRNAs) containing 2nt 3’ overhangs. These siRNAs are incorporated into an RNA-
induced silencing complex (RISC), which mediates the degradation of messenger 
RNAs (mRNAs) with sequence complementarity to the siRNA. 
A second, very similar process is silencing mediated by microRNAs (miRNAs). These 
are also short (~ 21nt) RNAs that are excised from genome-encoded precursors 
folding into dsRNA-like hairpins. Different to siRNAs, miRNAs carry out their silencing 
function by base pairing to the 3’-untranslated region (3‘-UTR) of target mRNAs and 
consequently inhibit protein accumulation. One further difference is that siRNAs 
exhibit perfect complementarity in the central part of the siRNA-mRNA duplex, 
whereas miRNA-mRNA duplexes are characterized by bulges or other irregularities. 
Although their mode of action seems to be different, miRNA and siRNA pathways are 
very similar and involve similar and in part identical machinery components (e.g. 
Dicer, Argonautes). 
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Post-transcriptional gene regulation by microRNAs (miRNAs) 
MicroRNAs (miRNAs) are defined as 21-23nt long, non-protein-coding RNAs that are 
generated from endogenous hairpin-shaped transcripts (Bartel, 2004). Mature 
miRNAs and Argonaute (AGO) form the RNA-induced silencing complex (RISC) 
mediating post-transcriptional gene silencing by imperfect complementary base-
pairing with target mRNAs, usually in the 3’ untranslated region (3’-UTR). 
Target mRNA binding inhibits protein synthesis either by repressing translation 
and/or by deadenylation and subsequent degradation of mRNA targets (reviewed in 
Filipowicz et al., 2008). 
Biogenesis of miRNAs and their assembly into ribonucleoproteins 
Transcription of primary transcripts, termed pri-miRNAs, from miRNA genes mainly 
by RNA polymerase II are usually several kilobases long and contain local stem-loop 
structures. 
The first step in maturation is nuclear cleavage of the pri-miRNA at the stem of its 
hairpin structure. This reaction is mediated by the microprocessor complex consisting 
of the 160kD sized RNase III-like enzyme Drosha and its cofactor DiGeorge 
syndrome critical region 8 (DGCR8). DGCR8, harboring two double-stranded RNA 
binding domains (dsRBDs), recognizes the double stranded stem and the single-
stranded flanking region of the pri-miRNA. Its catalytical partner Drosha cleaves the 
substrate ~11bp away from the ssRNA-dsRNA junction (Han et al., 2006). Drosha 
and DGCR8 regulate each other post-transcriptionally and furthermore DGCR8 
stabilizes the Drosha protein via protein-protein interaction (Han et al., 2009). 
Cleavage by the microprocessor complex releases a short ~60-70nt hairpin, termed 
pre-miRNA, having a 2nt 3’ overhang (Lee et al., 2002). Pre-miRNAs are bound by 
exportin 5 (EXP5), a Ran-dependent importin-beta-related transport receptor, at the 
14bp dsRNA stem along with a short 1-8nt 3’ overhang (Kutay et al., 1998, Zeng and 
Cullen, 2004). 
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Nuclear export occurs through nuclear pore complexes, which are large 
proteinaceous channels embedded in the nuclear membrane (Nakielny and 
Dreyfuss, 1999). EXP5 cooperatively binds to pre-miRNAs and the GTP-bound form 
of the cofactor Ran in the nucleus. Hydrolysis of GTP in the cytoplasm releases the 
pre-miRNA cargo of EXP5. (Yi et al., 2003, Bohnsack et al., 2004, Lund et al., 2004) 
Following export from the nucleus, pre-miRNAs are cleaved by the ~200kD RNase 
III-like enzyme Dicer (complexed with TAR RNA binding protein [TRBP]) in the 
cytoplasm (Chendrimada et al., 2005). Dicer measures from the terminus of the pre-
miRNA releasing ~22nt miRNA duplexes with protruding 2nt 3’ends similar to small 
interfering RNA (siRNAs) (Ma et al., 2004, Macrae et al., 2006). 
The resulting miRNA duplexes are assembled into ribonucleoprotein (RNP) 
complexes called micro-RNPs (miRNPs) or miRNA-induced silencing complexes 
(miRISCs). Loading of miRNA duplexes in miRNP complexes is a dynamic, but so far 
not well understood process, that is usually coupled to pre-miRNA processing by 
Dicer (reviewed in Rana, 2007). 
The catalytical component of miRNPs is the Argonaute (AGO) protein family (Hock 
and Meister, 2008). Generally, the strand with the 5’ terminus located at the 
thermodynamically less-stable end of the duplex is selected to function as a mature 
miRNA. The strand that gets selected for incorporation into RISC is called guide 
strand. The other strand, termed passenger strand (or miRNA*), is normally 
degraded by exoribonucleases (Ramachandran and Chen, 2008, Chatterjee and 
Grosshans, 2009). Depending on the availability of mRNA targets and on the activity 
of different accessory proteins the ratio of miRNA to miRNA* can vary in certain 
tissues or developmental stages (Chiang et al., 2010, Krol et al., 2004, Ro et al., 
2007). Moreover, certain miRNA duplexes can produce two functional miRNAs 
targeting different populations of mRNA targets (Okamura et al., 2008). 
In human all four Argonaute proteins known (AGO1-4) are functioning in miRNA 
mediated translational repression. Additionally AGO2 has a RNase H-like P-element 
induced wimpy testis (PIWI) domain and can therefore cleave mRNA at the centre of 
the siRNA-mRNA duplex in RNAi (Tolia and Joshua-Tor, 2007). 
A schematic summary of the miRNA biogenesis pathway can be found in Figure 1. 
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Figure 1. Biogenesis of miRNAs and their assembly into ribonucleoproteins 
Canonical miRNA genes are transcribed to generate pri-miRNAs. The initiation step is 
mediated by the microprocessor complex (Drosha-DGCR8) generating 60-70nt pre-
miRNAs. Nuclear export by EXP5-RanGTP is followed by cleavage to miRNA duplexes by 
Dicer in the cytoplasm (modified from Filipowicz et al., 2008) 
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Targets of miRNAs and modes of action 
In most cases metazoan miRNAs pair imperfectly in the 3’-UTR of their mRNA 
targets according to a set of rules defined by experimental and bioinformatic studies 
(Grimson et al., 2007). 
The most stringent rule is the perfect and contiguous base pairing of miRNA 
nucleotides 2 to 8, which represents the “seed” region (Brennecke et al., 2005, Lewis 
et al., 2005). Another rule is the preclusion of AGO-mediated endonucleolytic 
cleavage of mRNA through bulges and mismatches in the central region (position 10-
12) of the miRNA-mRNA duplex (reviewed in Bartel, 2009). To stabilize the 
interaction a reasonable complementarity to the 3’half of the miRNA must be given, 
as well as an AU-rich neighborhood improves site efficacy. In general, accessibility of 
binding sites has an important effect on miRNA-mediated repression (Kertesz et al., 
2007, reviewed in Filipowicz et al., 2008). Importantly, effective repression requires 
multiple sites for the same or different miRNAs (Doench and Sharp, 2004, Grimson 
et al., 2007, Nielsen et al., 2007). 
Possible mechanisms of the miRNA mediated post-transcriptional gene repression 
are deadenylation followed by decapping and degradation, repression of translational 
initiation and blocking of translational elongation (Behm-Ansmant et al., 2006, Wu et 
al., 2006, Humphreys et al., 2005, Pillai et al., 2005, Maroney et al., 2006, Nottrott et 
al., 2006, Petersen et al., 2006, reviewed in Chekulaeva and Filipowicz, 2009). 
The 182 kDa glycine-tryptophan protein (GW182), in concert with the other core 
components of miRISC, mediates the deadenylation of the target mRNAs. The 
GW182 amino-terminal part contains GW repeats that interact with AGO protein, 
while the carboxyterminal part interacts with poly(A) binding protein (PABP) and 
recruits the CCR4 and CAF1 deadenylases (Eulalio et al., 2009). 
Translationally inactive eukaryotic mRNA assembled in repressive miRNPs usually 
accumulate in discrete cytoplasmic foci known as P-bodies (also known as GW-
bodies) (reviewed in Eulalio et al., 2007). Under stress conditions stress granules 
(SG) can be formed, that also contain repressed mRNAs (reviewed in Anderson and 
Kedersha, 2009). 
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Regulation of miRNA gene transcription 
Expression of miRNAs can be regulated by transcription factors in a tissue-specific or 
developmental-specific manner. Autonomously expressed miRNA gene promoters 
contain CpG islands, TATA box sequences, initiation elements and certain histone 
modifications (Ozsolak et al., 2008, Corcoran et al., 2009). Their similarity to protein-
coding genes indicate that the promoters of miRNA genes are controlled by 
transcription factors (TFs), enhancers, silencing elements and chromatin 
modifications (reviewed in Krol et al., 2010). 
The transcription factor PITX3 stimulates transcription of miRNA 133b, which then 
suppresses PITX3 transcription. This negative autoregulatory feedback loop controls 
dopaminergic neuron differentiation (Kim et al., 2007). The c-Myc oncogenic 
transcription factor (Myc) and V-myc myelocytomatosis viral related oncogene, 
neuroblastoma derived (N-Myc) both stimulate expression of the miR-17-92 
oncogenic cluster in lymphoma cells (O'Donnell et al., 2005) and miR-9 in 
neuroblastoma cells, but also inhibit the expression of several tumour suppressor 
miRNAs (e.g., miRNA 15a) by direct binding of myc to miRNA promoters (O'Donnell 
et al., 2005, Ma et al., 2008, Chang et al., 2008). Expression of miRNA-34 and 
miRNA-107 families, which enhance cell cycle arrest and apoptosis, can be 
stimulated by p53 (He et al., 2007). The transcriptional repressor, RE1 silencing 
transcription factor (REST) prevents transcription of the miRNA-124 promoter in 
neuronal progenitors and non-neuronal cells by recruiting histone deacetylases and 
the methyl CpG binding protein MeCP2 (Conaco et al., 2006). 
Promoter methylation by the DNMT1 and DNMT3b DNA methyltransferases 
regulates transcription of miRNA-148a, miRNA-34b/c, miRNA-9 and let-7 (Han et al., 
2007). 
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Post-transcriptional regulation of miRNA maturation 
There are several positive and negative posttranscriptional regulators of microRNA 
biogenesis: 
Drosha can target hairpins in DGCR8 mRNAs and facilitate its degradation, whereas 
DGCR8 can interact with the Drosha middle domain thereby stabilizing Drosha (Han 
et al., 2009, Triboulet et al., 2009). Heme can also bind to DGCR8 and facilitate pri-
miRNA processing by promoting dimerisation (Faller et al., 2007). 
The microprocessor complex normally only consists of Drosha and DGCR8 protein, 
but can form a larger complex that contains RNA helicases, double stranded RNA 
binding proteins (dsRBDs), heterogeneous nuclear ribonucleoproteins and Ewing’s 
sarcoma proteins (Gregory et al., 2004). The DEAD-box RNA helicases p68 (DDX5) 
and p72 (DDX17) were identified as part of the microprocessor complex. Depletion of 
p68 (DDX5) and p72 (DDX17) reduces the expression of several miRNAs (and pre-
miRNAs) without concurrent changes in pri-miRNAs (Fukuda et al., 2007).In cancer 
cells, the tumor suppressor p53 can associate with p68 (DDX5) and facilitate the 
maturation of a restricted population of pri-miRNAs in response to DNA damage 
(Suzuki et al., 2009). 
The heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) can specifically bind to 
pri-miRNA-18a (a member of the miRNA-17-92 cluster) via its RNA Recognition 
Motifs (RRM) to facilitate its processing (Guil and Caceres, 2007). Drosha cleavage 
is increased via binding to the hairpin-loop to change the conformation, thereby 
creating a more favorable cleavage site for Drosha (Michlewski et al., 2008). Also the 
single-strand RNA binding protein KH-type splicing regulatory protein (KSRP) can 
bind to the terminal loop of many miRNA precursors (Trabucchi et al., 2009). KSRP 
interacts with single-strand AU-rich-element-containing mRNAs and is a key mediator 
of mRNA decay (Gherzi et al., 2004). Interaction of KSRP with both Dicer and 
Drosha promotes target miRNA maturation (Trabucchi et al., 2009). 
Transforming factor-β (TGF-β) and bone morphogenetic factors (BMPs) can recruit 
ligand specific signal transducers (SMAD proteins) to pri-miRNA-21 transcripts in 
complex with the RNA helicase p68 (DDX5). This promotes the processing of pri-
miRNA-21 to pre-miRNA-21 thereby increasing the expression of miRNA-21 (Davis 
et al., 2008). SMAD proteins bind a consensus sequences (R-SBE) within the stem 
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region of the primary transcripts which can be found in 20 miRNAs (T/B-miRs) 
regulated by TGF-β and BMPs (Davis et al., 2010). 
The best studied negative regulator of miRNA biogenesis is Lin28. This 
developmentally regulated RNA binding protein uses multiple mechanisms to repress 
the maturation of the let-7 miRNA family, which is derived from 12 precursor 
transcripts that contain nine mature miRNA sequences. Lin28 is necessary and 
sufficient for blocking microprocessor-mediated cleavage of pri-let-7 miRNAs 
(Viswanathan et al., 2008). Lin28 binds to the terminal loop of pri-let-7 and acts as a 
competitor for Drosha (Newman et al., 2008, Piskounova et al., 2008). Lin28 is 
abundant in the cytoplasm suggesting that this may be the primary interaction with 
let-7 precursors (Balzer and Moss, 2007). Binding of Lin28 to pre-let-7 competes with 
Dicer binding to inhibit Dicer processing (Rybak et al., 2008). Additionally, Lin28 
recognizes a tetra-nucleotide sequence motif (GGAG) in the terminal loop of let-7. 
This recruits TUTase4 (TUT4) to promote 3’-uridylation of pre-let-7 thereby inhibiting 
Dicer cleavage and leading to degradation of pre-let-7 by an unidentified nuclease 
activity (Heo et al., 2008, Heo et al., 2009). 
A negative feedback loop is formed when Dicer mRNA is targeted by let-7 in the 
coding region, broadly influencing miRNA biogenesis (Forman et al., 2008). In 
contrast to Lin28, which is restricted to the let-7 family, the NF90/NF45 heterodimer 
can downregulate the maturation of a broader spectrum of miRNA precursors 
(Sakamoto et al., 2009). The NF90 subunit contains two dsRBDs that recognize the 
stem of pri-miRNAs in a sequence independent way, explaining interaction with a 
broad range of miRNA precursors (Chang and Ramos, 2005). Interaction with the 
stem of pri-miRNAs blocks binding of DGCR8 and subsequent Drosha cleavage 
(Sakamoto et al., 2009). 
Dicer is not only involved in the cleavage of pre-miRNAs but also has a crucial role in 
miRISC loading (Carthew and Sontheimer, 2009). Addition of TRBP and removal of 
Dicer’s amino terminal helicase domain stimulates catalytical activity of human Dicer 
(Ma et al., 2008). Dicer activity can also be modulated by proteolysis or by changing 
its specificity towards DNA (Lugli et al., 2005, Zhang et al., 2002, Nakagawa et al., 
2010). 
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Phosphorylation of TRBP in the mitogen-activated protein kinase (MAPK) 
extracellular signal-regulated kinase (ERK) pathway stabilizes the Dicer-TRBP 
complex to enhance miRNA production (Paroo et al., 2009). 
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A role for miRNAs in animal differentiation and development 
In 1993, the first small RNA, lin-4, was discovered by forward genetics in C. elegans 
acting in the heterochronic pathway to control developmental timing (Lee et al., 1993, 
Wightman et al., 1993). Since then the number of known small RNAs has increased 
substantially revealing functions in almost every biological process, including 
developmental timing, cell differentiation, cell proliferation, apoptosis, metabolic 
control, transposon silencing and antiviral defense (reviewed in Bushati and Cohen, 
2007). Mouse and human ES express a unique set of miRNAs that are 
downregulated upon differentiation (Houbaviy et al., 2003, Suh et al., 2004). 
Dicer-mutant mice, arrest in development and die during gastrulation, before axis 
formation, while Dicer-deficient ES cells are viable, but do not form mature miRNAs 
and fail to differentiate in vitro and in vivo (Bernstein et al., 2003, Kanellopoulou et 
al., 2005). Development of mouse oocytes requires Dicer-dependent miRNA 
biogenesis for normal mouse embryo development (Murchison et al., 2007, Tang et 
al., 2007). Differentiation and patterning in other Dicer-depleted tissue is normal, but 
morphogenesis of hair follicles, lung epithelium, and limbs is perturbed (Andl et al., 
2006, Harfe et al., 2005, Harris et al., 2006, Yi et al., 2006). In early zebrafish 
development Dicer-depleted embryos develop normally but arrest after 8 days. They 
die within 2-3 weeks when the maternal Dicer is running out and they are depleted of 
mature miRNAs (Wienholds et al., 2003). 
Taken together, these studies suggest that miRNAs play important roles in cell 
differentiation and are required in a broad range of biological processes during 
animal development. To answer the question of what aspect of their biology is being 
regulated the identification of further miRNAs and their targets will be needed for a 
deeper understanding of their roles in development. 
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Xenopus life cycle 
Xenopus laevis (African clawed frog) is a species of South African aquatic frog that 
can grow to a length of 12cm (5 inch). The average life span ranges from 5 to 15 
years with some animals recorded to have lived for 20 years. 
Unlike other model organisms Xenopus does not have a short generation time and 
genetically simplicity (it is tetraploid). To reach sexual maturity the frog has to grow 
for 1 to 2 years. 
However, Xenopus is an important model organism in developmental biology 
because of its large and easy manipulable embryo. Xenopus oocytes provide an 
excellent microinjection and expression system to study early vertebrate 
development. 
Figure 2. Life cycle of the African clawed frog Xenopus laevis. 
Oocytes develop from Stage I to Stage VI and mature to eggs by progesterone (Dumont, 
1972). The fertilized egg undergoes gastrulation and forms a multicellular tadpole within a 
day or two. Amphibian metamorphosis then grows the tadpole to an adult frog (modified from 
Alberts, 2002). 
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Xenopus laevis oocytes and eggs 
Early development 
Xenopus oocyte maturation starts with a cell that is only slightly larger than a typical 
somatic cell. The meiotic cycle starts with one round of replication and enters meiotic 
prophase, during which chromosomes condense, the homologs pair and meiotic 
recombination occurs. 
The oocyte develops for several months in a G2-like growth phase, with active 
transcription, an intact germinal vesicle and partially decondensed chromatin (Ferrell, 
1999). Once the oocyte has grown from stage I to stage VI it can remain for years in 
meiotic diplotene, which resembles a G2 phase arrest state (see Figure 2) (Dumont, 
1972). Stage VI oocytes are very large cells of about 1.3mm in diameter and an 
intracellular volume of 1μl  which is 106 times the size of a typical somatic cell 
(Hausen and Riebesell, 1991). The oocyte also has a huge nucleus, termed germinal 
vesicle, that is 300-400nm in diameter residing in the darkly pigmented animal 
hemisphere (Ferrell, 1999). 
The accumulated material in the oocyte cytoplasm includes energy sources and 
energy-producing organelles (yolk and mitochondria), the enzymes and precursors 
for DNA, RNA and protein synthesis, stored messenger RNAs, structural proteins 
and morphogenetic regulatory factors that control early embryogenesis (Gilbert, 
2000). 
During the diplotene stage of meiotic prophase I so called lampbrush chromosomes 
can be observed even under light microscope (Old et al., 1977). These are sites of 
active RNA synthesis and stretch out in large loops of DNA. 
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Maturation 
In response to gonadotropic hormones secreted by the pituitary gland, follicle cells 
synthesize and release the steroid hormone progesterone that initiates maturation of 
oocytes (Fortune et al., 1975). 
The maturing oocyte reenters meiosis I, undergoes germinal vesicle breakdown 
(GVBD), and completes the first meiotic division by emitting the first polar body 
(Ferrell, 1999). GVBD can be scored by an appearing white spot at the animal pole, 
resulting from rearrangement of cortical pigment granules. 
Entry into the mitotic (M) phase of the cell cycle (in both meiosis and mitosis) is 
regulated by mitosis-promoting factor, or MPF (originally called “maturation-
promoting factor” after its meiotic function) (see Figure 3). MPF contains two 
subunits, cyclin B and the p34cdc2 protein (a cyclin-dependent-kinase). 
 
Figure 3. Xenopus oocyte maturation 
Progesterone stimulation activates the M-Phase promoting factor (MPF) and Mos-Kinase. 
This guides oocytes from meiotic prophase I to meiosis II (modified from Mendez and 
Richter, 2001). 
 
Introduction 
16 
Progesterone stimulation turns the components present in the oocyte, into an active 
MPF by mediating polyadenylation of the maternal c-mos mRNA that has been 
stored in the cytoplasm (Sagata et al., 1988, Sagata et al., 1989, Sheets et al., 1995). 
This leads to translation of the 39-kDa phosphoprotein c-mos, which has an 
important role in releasing the egg from its dormancy. The protein can only be 
detected during oocyte maturation and is destroyed quickly upon fertilization. 
Inhibition of c-mos translation (by injecting c-mos antisense oligos into the oocyte) 
blocks GVBD and the resumption of oocyte maturation (Sagata et al., 1988). The c-
mos protein activates a phosphorylation cascade that phosphorylates and activates 
the p34 subunit of MPF (Ferrell and Machleder, 1998, Ferrell, 1999). The active MPF 
allows GVBD and the chromosomes go through the first meiotic division and the 
prophase of the second meiotic division. 
In metaphase of the second meiotic division the egg is again arrested by combined 
activity of c-mos and cyclin-dependent kinase 2 (cdk2) (Gabrielli et al., 1993). These 
two proteins are subunits of a cytostatic factor (CSF) which is the product of the c-
mos proto-oncogene. CSF blocks cell cycles in metaphase by preventing the 
degradation of cyclin (Masui, 1974, Castro et al., 2001). 
Fertilization releases the block in metaphase of the second meiotic division by 
calcium ion flux thereby activating the calcium binding protein calmodulin (Zhang and 
Yuan, 1998). Calmodulin activates calmodulin-dependent protein kinase II, which 
inactivates p34, and calpain II, a calcium-dependent protease that degrades c-mos 
(Watanabe et al., 1989, Lorca et al., 1993) Therefore CSF is inactivated and 
subsequent cyclin degradation completes the meiotic division. 
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Cytoplasmatic polyadenylation regulates mRNA translation during maturation 
Mos, cyclin B and other dormant mRNAs present in the Xenopus oocyte contain 
short poly(A) tails (~20-40nt long). Translation of these mRNAs can only take place 
when the length is elongated to 150nt by poly(A) polymerases (reviewed in Mendez 
and Richter, 2001). 
Two elements in the 3‘-UTR of those dormant mRNAs are required for the 
cytoplasmatic polyadenylation and subsequent translational activation: The 
hexanucleotide AAUAAA and the cytoplasmic polyadenylation element (CPE) with 
the general consensus sequence UUUUUAU (Fox et al., 1989, McGrew et al., 1989, 
McGrew and Richter, 1990, Barkoff et al., 2000). The timing of polyadenylation may 
be regulated by the precise sequence of the CPE, the number of copies of the CPE, 
the distance between the CPE and the hexanucleotide, or sequences adjacent to the 
CPE (reviewed in Mendez and Richter, 2001). 
Initiation of maturation by progesterone activates the serine/threonine protein kinase 
Eg2, phosphorylating CPEB at serine residue 174 (Andresson and Ruderman, 1998, 
Mendez et al., 2000a). CPEB is a highly conserved, sequence-specific RNA binding 
protein harboring a Zinc finger domain and two RNA recognition motifs (RRM) bound 
to CPEs (Hake and Richter, 1994, Stebbins-Boaz et al., 1996). Phosphorylation of 
CPEB increases the affinity of CPEB for CPSF, a cleavage and polyadenylation 
specifity factor. Therefore, CPEB stabilizes the interaction of CPSF to the AAUAAA 
sequence by recruiting poly(A) polymerase to the end of the mRNA (Fox et al., 1992, 
Bilger et al., 1994, Dickson et al., 1999, Mendez et al., 2000b). 
The newly elongated poly(A) tail can then recruit translation initiation factors through 
its association with Poly(A) binding protein (PABP). This helps forming a complex of 
the transcriptional initiation factors eIF4G andeIF4E resulting in the initiation of 
translation (reviewed in Radford et al., 2008). 
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miRNAs in Xenopus development 
In Xenopus, miRNA genes are predominantly positioned within introns of 
proteincoding and non-proteincoding RNA Polymerase II-transcribed genes. The 
genes of miRNAs were also located in pre-mRNA exons and positioned intergenically 
between known protein-coding genes and clustered throughout the genome, 
indicating the potential for the cotranscription and coordinate expression of miRNAs 
located in a given cluster. Comparison of Xenopus tropicalis and Xenopus laevis 
blots revealed comparable expression profiles, although several miRNAs exhibited 
species-specific expression. Differences in the tissue specific expression profile of 
pri-miRNAs compared to mature miRNA expression profile argue for post-
transcriptional regulation of miRNA expression in Xenopus (Tang and Maxwell, 
2008). Nuclear microinjection experiments in Xenopus laevis oocytes revealed 
efficient export of pre-miRNAs to the cytoplasm mediated by EXP5 (Bohnsack et al., 
2004, Lund et al., 2004). Cytoplasmic Dicer processing can be detected in Xenopus 
oocytes and is further increased in eggs (Lund and Dahlberg, 2006). During Xenopus 
laevis development from oocyte stage to tadpole stage a variety of miRNAs start to 
be expressed. Most of these miRNAs emerged at a specific stage and were 
continuously expressed until the tadpole stage (Watanabe et al., 2005). 
In Xenopus laevis embryogenesis miRNA-427 mediates the rapid deadenylation of 
maternal mRNAs after the midblastula transition (MBT). By MBT, the stage when the 
embryonic cell cycle is remodeled and zygotic transcription of mRNAs is initiated, 
each embryo has accumulated ׽109 molecules of miRNA-427 processed from 
multimeric pri-miRNA 427 transcripts synthesized after fertilization (Lund et al., 
2009). Analysis of the spatiotemporal expression of miRNAs in Xenopus tropicalis 
embryogenesis revealed that many miRNAs, that gave specific expression patterns, 
are present in neuronal tissues (Walker and Harland, 2008). 
  
Introduction 
19 
RNA editing 
RNA editing is a post-transcriptional mechanism that alters the nucleotide sequence 
of its RNA substrate from the DNA sequence encoded by the corresponding gene in 
the genome. 
The phenomenon of RNA editing was first discovered in kinetoplast protozoa as the 
deletion or insertion of uridine nucleotides (Benne et al., 1986). Since then, many 
other RNA editing mechanisms were discovered, grouped in either insertion/deletion 
of nucleotides or nucleotide modification (reviewed in Gott and Emeson, 2000). The 
best characterized mechanism of RNA editing by base modification are C-to-U 
deamination and A-to-I deamination (reviewed in Keegan et al., 2001, Alfonzo et al., 
1997). 
Editing in the coding region of an mRNA can change the protein coding sequence by 
replacing single nucleotides or by insertion or removal of stop codons. Additionally, 
splice sites can be changed and RNA stability can be influenced, affecting splice 
efficiency and alternative splicing decisions. Consequently, RNA editing can increase 
the number of different functional proteins derived from a given gene (reviewed in 
Bass, 2002). 
The most widespread type of RNA editing in higher eukaryotes is the conversion of 
A-to-I, which is interpreted as guanosine by the translation or splicing machinery. 
RNA A-to-I editing by ADAR Deaminases 
The hydrolytic deamination of adenosine to inosine (6-deaminated inosine, see 
Figure 4) is mediated by ADAR (adenosine deaminase acting on RNA) enzymes. 
ADARs are targeting dsRNA via their double-stranded RNA binding domains 
(dsRBDs), which are present on all members of the protein family. ADARs were first 
discovered in Xenopus laevis eggs and embryos for their dsRNA unwinding activity 
and later discovered to be dsRNA specific adenosine deaminases (Bass and 
Weintraub, 1987, Bass and Weintraub, 1988). 
ADAR enzymes probably evolved from the functionally and structurally related 
adenosine deaminases that act on tRNAs (ADATs) (Gerber et al., 1998). 
Introduction 
20 
 
 
Figure 4. Deamination of adenosine to inosine by ADARs 
During A-to-I RNA editing a hydrolytic deamination reaction converts adenosine to inosine 
(from Nishikura, 2010). 
In vertebrates, three ADAR family members are known (ADAR1-3), where ADAR1 
has two translational products: an interferon inducible 150kD shuttling protein 
(ADAR1p150) and a constitutively expressed 110kD shuttling protein (ADAR1p110) 
(Patterson and Samuel, 1995). ADAR1 and ADAR2 have enzymatic activity, whereas 
for ADAR3 (also having a conserved deaminase domain) so far no activity has been 
described (Gerber et al., 1997). 
ADAR enzymes harbor a conserved catalytic deaminase domain at the 
carboxyterminal end, and a variable number of dsRBDs at the aminoterminal end 
(reviewed in Lunde et al., 2007). The dsRNA binding motif of dsRBDs was first 
discovered in Drosophila staufen and in Xenopus laevis RNA binding protein A 
(Xlrbpa) and regulates numerous biological processes such as RNA localization, 
RNA interference, RNA processing and RNA editing (St Johnston et al., 1992, 
reviewed in Doyle and Jantsch, 2002). 
ADAR targets both intermolecular and intramolecular dsRNAs of >20 base pairs (bp) 
(two turns of the dsRNA helix) as substrates (Nishikura et al., 1991). In long, 
completely base paired dsRNA (>100bp), including many adenosine residues editing, 
occurs non-selectively. In contrast, long but partially dsRNAs containing mismatched 
bases, bulges and loops (imperfect dsRNAs) as well as short dsRNAs (~20-30bp) 
are edited selectively (Lehmann and Bass, 1999). 
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Base modification by hydrolytic deamination in A-to-I editing in the coding region of 
mRNA can create, delete or alter the meaning of a codon resulting in a diversification 
of their protein functions (reviewed in Bass, 2002). Protein coding RNA targets of 
ADARs are mammalian glutamate receptor (GluR), mammalian serotonin receptor 
(5-HT2CR), human potassium channel Kv1.1, squid Kv1.1A, Drosophila Na+ channel 
and hepatitis delta virus antigen (Higuchi et al., 1993, Burns et al., 1997, 
Hoopengardner et al., 2003, Rosenthal and Bezanilla, 2002, Reenan et al., 2000, 
Polson et al., 1996). In most cases, RNA editing of these protein coding genes 
results in the generation of protein isoforms leading to the modification of ion 
channel/neurotransmitter receptor functions (Seeburg and Hartner, 2003). Editing 
has been detected within viral transcripts and in tRNAs but the vast majority of A-to-I 
editing sites are noncoding sequences (Cattaneo et al., 1988, Polson et al., 1996, 
Laforest et al., 1997). Frequent targets are 5’ and 3’ UTRs and intragenic 
retrotranspons elements, such as Alu and long interspersed elements (LINEs) 
(Levanon et al., 2004, Athanasiadis et al., 2004, Morse et al., 2002, reviewed in 
Nishikura, 2006). A-to-I editing can also alter RNA stability by inosine to uridine 
binding, which can only form one hydrogen bond and thereby weakens RNA strand 
pairing. 
Further, accumulating evidence suggests an interaction of A-to-I RNA editing on the 
RNAi pathway thereby modulating the efficacy of RNAi (reviewed in Nishikura, 2006, 
Nishikura, 2010). Precursors of certain miRNAs are A-to-I edited having important 
implications on their processing, expression and function of mature miRNAs (Luciano 
et al., 2004, Blow et al., 2006, Yang et al., 2006, Kawahara et al., 2007a, Kawahara 
et al., 2007b). 
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A-to-I RNA editing of miRNA precursors 
A-to-I RNA editing of miRNA precursors by ADAR1 and ADAR2 was first described 
for miRNA-22 followed by miRNA-151, miRNA-197, miRNA-223, miRNA-376a, 
miRNA-379, miRNA-99a and miRNA-1-1, miRNA-142, miRNA-143 (Luciano et al., 
2004, Blow et al., 2006, Calin and Croce, 2006). 
Editing of the specific sites +4 and +5 of pri-miRNA-142 (see Figure 5) is sufficient 
and necessary to block cleavage by the microprocessor complex in vitro (Yang et al., 
2006). Consistently, in Adar1-/- or Adar2-/- mice levels of miRNA-142 expression is 
substantially increased (Yang et al., 2006). Further, highly edited pri-miRNA-142 is 
degraded in vitro by Tudor staphylococcal nuclease (Tudor-SN), a nuclease that 
cleaves hyper-edited dsRNA substrates containing multiple I-U base pairs (Yang et 
al., 2006, Scadden, 2005). 
 
Figure 5. RNA editing of pri-miRNA-142 
Editing of site +4 and +5 blocks processing of the microprocessor complex in vitro (taken 
from Yang et al., 2006) 
 
Downstream processing steps are also affected by RNA editing: pri-miRNA-151 has 
a major (+3) and a minor ADAR1 editing site (-1) on its antisense strand near the 
Dicer cleavage site (see Figure 6). Editing of these sites had no effect on Drosha 
cleavage but inhibited Dicer cleavage, leading to accumulation of edited 
pre-miRNA-151 in the cytoplasm (Kawahara et al., 2007a). 
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Figure 6. RNA editing of pri-miRNA-151 
Editing of site +3 and -1 blocks cleavage by Dicer (taken from Kawahara et al., 2007a) 
 
Another miRNA that is edited is encoded by the miRNA-376 cluster. This cluster is 
maternally imprinted and consists in human of six, in mouse of three miRNA-376 
genes. High editing levels in the mouse brain were detected at site +4 (by ADAR2) 
and site +44 (by ADAR1). These editing sites are located in the middle of the 5’-
proximal half “seed” region of miRNA 376-5p and 3p strands that are critical for 
miRNA hybridization to their targets. 
Endogenous expression of a predicted target of edited miRNA-376a, PRPS1, a 
mouse protein involved in purine metabolism and uric acid synthesis, was dependent 
upon ADAR2 and edited miRNA-376a. It was specifically shown, that in the cortex of 
ADAR2−/− mice, PRPS1 protein and uric acid levels were ׽2-fold higher compared to 
wild type mice (Kawahara et al., 2007b). These findings suggest the redirection of 
silencing target genes by edited miRNAs. 
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Material and Methods 
Xenopus laevis oocytes and eggs were stored in OR2-buffer at 16°C. Oocytes were 
matured to eggs by adding 20μg/ml progesterone and incubation at 16°C o/n. 
Xenopus laevis eggs were selected for visible germinal vesicle breakdown (GVBD). 
Nuclear and cytoplasmic injections were performed using WPI Nanoliter 2000™ 
microinjector. Extraction of total RNA was carried out using Invitrogen™ TRIzol 
reagent according to manufacturer’s protocol. RNA was separated on 10% 29:1-
Acrylamide:bisAcrylamide Gels containing 8M UREA in 1xTBE. 
DNA and RNA molecules were precipitated in 3x Vol. 96% EtOH and 1 10ൗ x Vol. 3M 
NaOAc pH=5.2. 
Buffers 
OR2 buffer: 82,5mM NaCl, 2,5mM KCl, 1mM CaCl2, 1mM MgCl2, 1mM Na2HPO4, 
5mM HEPES pH=8.3 
5:1 Isolation buffer pH=7.0: 83mM NaCl, 17mM KCl, 6,5mM Na2HPO4, 3.5mM 
KH2PO4, 3mM MgCl2 was added directly before isolation 
NET-2: 150mM NaCl; 50mM Tris pH7.4; 0.05% NP40 
20x SSC, pH=7.0: 3M NaCl, 300 mM tri-Sodium citrate dihydrate 
10xTBE pH=8.3: 1liter: 108g Tris base; 55g boric acid; 40ml 0.5M EDTA 
50xTAE: 1 liter: 242g Tris base; 57ml glacial acetic acid, 18.6g EDTA 
2xTY: 1 liter: 10g yeast extract, 16g tryptone, 5g NaCl – for plates add 15g bacto 
agar 
1xTE: 10mM Tris pH7.5; 1mM EDTA 
Church & Gilbert buffer (Church and Gilbert, 1984): for 1 liter: 7% SDS; 1% BSA; 
1mM EDTA; 500 ml 2xNaHPO4 pH7.2 (1Liter 2xNaHPO4: 34g Na2HPO4.7H2O; 4 ml 
85% H3PO4) 
Urea loading buffer: 8M urea; 5mM Tris pH7.5; 0.5% (w/v) bromophenol blue; 0.5% 
(w/v) xylene cyanol FF; 20mM EDTA, pH8.0. 
All RNase sensitive assays were carried out with 1:2000 DEPC treated reagents. 
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Cloning of microRNA variants containing a T7 promoter 
To produce DNA contructs that can be in vitro transcribed by T7 RNA Polymerase 
miRNA sequences were PCR amplified from 1μg of genomic DNA. 
PCR reactions were performed using Fermentas™ Taq Polymerase and supplied 
reagents according to manufacturer’s protocol. 
PCR cycles: 5min 95°C, 40x (30sec Tm=55°C, 30sec 72°C, 30sec 95°C), 5min 72°C 
PCR products were cloned in Promega™ pGEM-Teasy vector and verified by 
sequencing. 
PCR primers (T7 RNA Polymerase promoter sequences underlined): 
T7 pre-miRNA-21 
Forward+T7 5’-TAATACGACTCACTATAGGGCTTATCAGACTGATGTT-3’ (MJ2267) 
Reverse 5’-AGAGCCCATCGACTGGT-3’ (MJ2268) 
T7 pri-miRNA-21 
Forward+T7 5’-TAATACGACTCACTATAGGACATCTCCATGGCTGTACC-3’ 
(MJ2265) 
Reverse 5’-ATGGTCAGATGAAAGATA-3’ (MJ2266) 
T7 pri-miRNA-29b-1 Forward+T7 
5’-TAATACGACTCACTATAGGGTCCTGGGTTTATTGTAAG-3’ (MJ2354) 
Reverse 5’-TTCTTTTGCTGTTGGTAGTGCAG-3’ (MJ2355) 
T7 pre-xtr-miRNA-148a (based on T7 prei xtr-miRNA-148a) 
Forward+T7 5’-TAATACGACTCACTATAGGAGTTCTGTGACACTTAGACTCT-3’ 
(MJ2847) 
Reverse 5’-ACAAAGTTCTGTAGTGCACTGA-3’ (MJ2848) 
T7 prei xtr-miRNA-148a (cloning intermediate to create pri-xtr-miRNA-148a) 
Forward+T7 
5’-TCTTGGGTTTATTGTAAGAGAGCATTATGAATAGTCTTTTAAATCAAAGTTCTG
TG-3’ (MJ2845) 
Reverse 5’-CAGACTCCCAAAACAAAGTTC-3’ (MJ2846) 
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T7 pri-xtr-miRNA-148a (based on T7 prei xtr-miRNA-148a) 
Forward+T7 5’-TAATACGACTCACTATAGGGTCTTGGGTTTATTGTAAGAGAGC-3’ 
(MJ2844) 
Reverse 
5’-TTCTTTTGCTGTTGGTAGTGCAGCGCAGCCAGACTCCCAAAACAAAGTTC-3’ 
(MJ2851) 
T7 prei-miRNA-142 (cloning intermediate to create pri-miRNA-142 variants) 
Forward+T7 5’-TAATACGACTCACTATAGGACGGACAGACAGACAGTGC-3’ 
(MJ2122) 
Reverse 5’-ATCTCCGAAGCCCACAGTAC-3’ (MJ2121) 
T7 pri-miRNA-142 (based on T7 prei-miRNA-142) 
Forward+T7 
5’-TAATACGACTCACTATAGGGTCTTGGGTTTATTGTAAGAGAGCATTATGAACG
GACAGACAGACAGTGCA-3’ (MJ2587) 
Reverse 
5’-TTCTTTTGCTGTTGGTAGTGCAGCGCAGCTATCTCCGAAGCCCACAGTAC-3’ 
(MJ2612) 
T7 pri-miRNA-142 pre-edited: A-to-G at position +4, +5 (based on T7 prei-
miRNA-142) 
(1) Forward 5’-GACAGACAGACAGTGCAGTCACCCATGGAGTAG-3’ (MJ2364) 
(1) Reverse 5’-ATCTCCGAAGCCCACAGTAC-3’ (MJ2121) 
(2) Forward+T7 
5’-TAATACGACTCACTATAGGGTCTTGGGTTTATTGTAAGAGAGCATTATGAACG
GACAGACAGACAGTGCA-3’ (MJ2587) 
(2) Reverse 
5’-TTCTTTTGCTGTTGGTAGTGCAGCGCAGCTATCTCCGAAGCCCACAGTAC-3’ 
(MJ2612) 
T7 pri-miRNA-142 degenerated CC: A-to-C at position +4, +5, +6 (based on T7 
prei-miRNA-142) 
(1) Forward 5’-GACAGACAGACAGTGCAGTCACCCATCCCGTAG-3’ (MJ2365) 
(1) Reverse 5’-GCCCACAGTACACTCATCCATCCCGTAGGAAAC-3’ (MJ2366) 
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(2) Forward+T7 
5’-TAATACGACTCACTATAGGGTCTTGGGTTTATTGTAAGAGAGCATTATGAACG
GACAGACAGACAGTGCA-3’ (MJ2587) 
(2) Reverse 
5’-TTCTTTTGCTGTTGGTAGTGCAGCGCAGCTATCTCCGAAGCCCACAGTAC-3’ 
(MJ2612) 
T7 pri-miRNA-142 degenerated GG: A-to-G at position +4, +5, +6 (based on T7 
prei-miRNA-142) 
(1) Forward 5’-GACAGACAGACAGTGCAGTCACCCATGGGGTAG-3’ (MJ2670) 
(1) Reverse 5’-GCCCACAGTACACTCATCCATGGGGTAGGAAAC-3’ (MJ2671) 
(2) Forward+T7 
5’-TAATACGACTCACTATAGGGTCTTGGGTTTATTGTAAGAGAGCATTATGAACG
GACAGACAGACAGTGCA-3’ (MJ2587) 
(2) Reverse 
5’-TTCTTTTGCTGTTGGTAGTGCAGCGCAGCTATCTCCGAAGCCCACAGTAC-3’ 
(MJ2612) 
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T7 in vitro transcription 
T7-microRNA constructs cloned in Promega™ pGEM-T easy vector were linearized 
by digestion using 1μl (10u) PdmI (XmnI) restriction enzyme (Fermentas, 2h – 37°C). 
PCR was performed on the linearized vector to create an upstream of T7 extended 
PCR template for in vitro transcription. 
PCR cycles: 5min 95°C, 40x (30sec Tm=55°C, 30sec 72°C, 30sec 95°C), 5min 72°C 
PCR products were checked on a 1.5%-TAE Agarose Gel and eluted for in vitro 
transcription using PeqLab™ elution kit. 
T7 in vitro transcription using 500ng of template DNA was performed in 10mM DTT, 
1xStratagene™ transcription buffer, NTPs (0.5mM GTP, 0.5mM CTP, 0.5mM UTP, 
0.1mM ATP), 30μCi [α-32P]ATP, 1μl (40u) Ribolock™ RNase Inhibitor and T7 
Polymerase. The reaction was incubated for 2h at 37°C, purified using Sephadex G-
25 columns and precipitated. 
Radiolabeled RNA in vitro transcripts were separated on 10% 29:1 AA:bisAA gels 
(8M UREA in 1xTBE), exposed on Kodak™ X-ray films, appropriate bands were cut 
out and eluted in 400μl elution buffer (500mM NH4OAc, 0.2%SDS, 100mM EDTA) 
o/n. Eluted samples were purified by Sephadex G-25 columns and precipitated. 
Northern Blotting 
Northern Blots were performed as described earlier (Pall and Hamilton, 2008) using 
semi-dry blotting technique. Northern Blot probes xtr-miRNA-101 
5’-CTTCAGTTATCACAGTACTGTA-3’ (MJ2521) and xtr-miRNA-148a 
5’-ACAAAGTTCTGTAATGCACTGA-3’ (MJ2523) were 5’-end labeled with 20μCi [γ-
32P] ATP by Fermentas™ PNK according to manufacturer’s protocol. 
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Recombinant N-terminal myc-tagged Drosha 
Recombinant N7myc-Drosha was cloned based C7myc-Drosha obtained from my 
supervisor Michael Jantsch. A 3’Poly-(A)-tail was added downstream the Drosha 
coding sequence (Figure 7). 
 
Figure 7. N7myc-Drosha-poly(A) cloned in pBluescript KS vector 
The Xenopus Drosha containing a 3’ Poly-(A)-sequence was cloned into pBluescript II KS 
vector. 
The Plasmid was linearized using 10u Fermentas™ XbaI restriction enzyme and in 
vitro transcribed using T7 RNA polymerase (as described before). 
N7myc-Drosha-Poly-(A) was injected in oocytes and incubated o/n. Next, half of the 
oocytes were matured to eggs in OR2-buffer containing 20μg/ml progesterone and 
incubated o/n. 
Immunoprecipitation (IP) of recombinant Drosha 
Oocytes and eggs (10 cells) injected with N7myc-Drosha-Poly(A) RNA were grinded 
and 100μl NET-2 buffer was added. The mixture was spun down for 5min at 
14000rpm and the supernatant was transferred in a fresh tube. An aliquot of one cell 
(10μl) was transferred in a fresh tube for Western Blotting. 
α-myc antibody 9E10 was coupled to Sepharose A beads (4mg beads in 5ml 9E10) 
o/n at 4°C. 
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Coupled antibody was washed 4x in NET-2 buffer and filled up to 500μl with NET-2 
buffer. Cell extracts were added and rotated for 1h at 4°C. The IP was washed four 
times in NET-2 buffer and filled up to 500μl NET-2 buffer. An aliquot of one cell (50μl) 
was transferred in a fresh tube for Western blotting. 
The rest of the IP was washed in 500μl 6.4mM MgCl2 and used for Drosha in vitro 
processing assay. 
Drosha in vitro processing assay 
This experiment was performed using immunoprecipitated N7myc-Drosha according 
to a protocol by the Narry Kim lab: 
http://www.narrykim.org/in_vitro_Drosha_processing.pdf 
Cloning and sequencing of pre-microRNAs 
Radiolabeled pri-microRNAs were microinjected in eggs and total RNA was extracted 
and separated on a 10% - 29:1 AA:bisAA Gel as described earlier. Putative pre-
microRNA bands were cut out, eluted and precipitated as described above. 
Eluted putative pre-microRNAs were labeled with 20μCi [γ-32P] by Fermentas™ 
PNK ATP according to manufacturer’s protocol. 
1st Ligation (3’Adapter): Precipitated putative pre-miRNA were resuspended in 16μl 
dH2O and 2μl of 200μM RNA-3’Adapter 5’-UCGUAUGCCGUCUUCUGCUUGU-3’ 
(MJ2440), 4μl 10x NEB™ T4 RNA Ligase Buffer, 1μl (40u) Fermentas™ Ribolock, 
16μl 50% PEG6000 and 1μl (20u) NEB™ T4 RNA Ligase were added. 
The reaction was incubated for 2h at 37°C. Another 1μl of NEB™ T4 RNA Ligase 
was added and the reaction was incubated for another 2h. The reaction was then 
precipitated and separated a 10% - 29:1 AA:bisAA Gel (8M UREA in 1xTBE). 
Putative pre-microRNA+3’Adapter bands were cut out, eluted and precipitated. 
2nd Ligation (5’Adapter): Precipitated putative pre-microRNAs were resuspended in 
16μl dH2O and 2μl of 200μM RNA-5’Adapter 
5’-GUUCAGAGUUCUACAGUCCGACGAUC-3’ (MJ2439), 4μl 10x NEB™ T4 RNA 
Ligase Buffer, 1μl (40u) Fermentas™ Ribolock, 16μl 50% PEG6000 and 1μl NEB™ 
T4 RNA Ligase were added. 
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The reaction was incubated for 2h at 37°C. Another 1μl (20u) NEB™ T4 RNA Ligase 
was added and the reaction was incubated for another 2h. The reaction was then 
precipitated and separated on a 10% - 29:1 AA:bisAA Gel (8M UREA in 1xTBE)l. 
Putative pre-microRNA+3’Adapter+5’Adapter bands were cut out, eluted and 
precipitated. 
Reverse transcription (RT): The precipitated putative pre-
microRNAs+3’Adapters+5’Adapters were resuspended in 11μl dH2O and 100ng of 
RT-primer 5’-CAAGCAGAAGACGGCATACGA-3’ (MJ2438) was added, heated up to 
70°C for 5min and immediately put on ice. 4μl Fermentas™ 5x RT-buffer, 2μl dNTPs 
(10mM each), 1μl (40u) Fermentas™ Ribolock and 1μl (200u) Fermentas 
RevertAid™ H Minus Reverse Transcriptase were added. The reaction was 
incubated for 5min at room temperature, 5min at 37°C, 60min on 42°C, stopped for 
10min at 70°C and precipitated. The synthesized cDNA was resuspended in 20μl 
dH2O. 
RT-PCR: 5μl (25%) of the resuspended cDNA were transferred in a fresh eppendorf 
tube and 1μl (100ng) of forward primer 5’-GTTCTACAGTCCGACGATCGCT-3’ 
(MJ2436) and 1μl (100ng) of reverse primer 
5’-AAGCAGAAGACGGCATACGAAAC-3’ (MJ2437), 5μl 10x Fermentas™ PCR 
buffer, 4μl MgCl2 (25mM), 1μl dNTPs (10mM each), 1μl Fermentas Taq-
Polymerase™  and 32μl dH2O were added. 
Control reactions without cDNA and without Fermentas™ Revertaid respectively 
were also performed. 
PCR-cycles: 5min 95°C, 25x (30sec 55°C, 30sec 72°C, 30sec 95°C), 5min 72°C 
RT-PCR-products were separated on 1.4% TAE Agarose Gel, cut out under UV-light 
and eluted in 30μl elution buffer using PeqLab™ elution kit. 
5μl of eluted RT-PCR products were ligated in 0.5μl (25ng) Promega™ pGEM-T easy 
vector by adding 2μl 10x Fermentas™ Ligation buffer, 1μl (5u) Fermentas™ T4 DNA 
Ligase, 11.5μl dH2O and incubating the reaction at 16°C o/n. 
The successful ligation was transformed into Xl1-blue competent E. coli cells, plated 
out on 2xTy+Amp plates (containing 5mM IPTG and 1mg X-Gal) and incubated at 
37°C o/n. White colonies were selected, grown in 3ml 2xTy+Amp medium o/n and 
plasmid DNA was extracted by Mini-Prep. 
Plasmid DNA was sent to the Institute of Botany, University of Vienna for sequence 
analysis. Sequencing primer: 5’-CGCCAGGGTTTTCCCAGTCACGAC-3’ (MJ004)
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Specific aims of the thesis 
1) Regulation of miRNA biogenesis during Xenopus oogenesis 
Gene regulation by miRNAs plays a pivotal role in animal development and 
differentiation (reviewed in Bushati and Cohen, 2007). In early Xenopus development 
miRNA expression is regulated in a stage and tissue specific manner (Tang and 
Maxwell, 2008, Watanabe et al., 2005). 
The objective of this study was to reveal the regulation of pri- and pre-miRNAs 
processing in different stages of Xenopus oogenesis and upon editing.  
By using oocytes as a model, we were thus able to follow the path of a particular 
miRNA through various processing steps by injecting the precursor miRNAs. 
We therefore cloned miRNA precursor contructs of the ubiquitous miRNA-21 
containing an upstream T7 promoter and in vitro transcribed them using T7 RNA 
Polymerase. The precursor miRNA molecules were investigated by establishing a 
RNA microinjection system in Xenopus stage VI oocytes and eggs. Nuclear injections 
of miRNA precursors were performed in combination with U3 snoRNA/U6 snRNA as 
positive nuclear retention controls. RNA samples were generated by radiolabeled T7 
Polymerase in vitro transcription using [α-32P]ATP. After injection and incubation 
RNA was extracted and analyzed PAA-Gels. 
2) Impact of RNA editing on pri-miRNA processing in vivo 
A-to-I RNA editing is mediated by ADAR enzymes, which were originally discovered 
in Xenopus laevis eggs and embryos as an unwinding activity and soon after as a 
dsRNA adenosine deaminase (Bass and Weintraub, 1987, Rebagliati and Melton, 
1987, Bass and Weintraub, 1988, Wagner et al., 1989). Tudor-SN, a specific 
ribonuclease targeting hyper-edited dsRNA, was shown to be active in Xenopus 
laevis oocyte extracts (Scadden and Smith, 2001b, Scadden, 2005). 
Studies on edited miRNAs have shown that RNA editing can strongly affect the 
processing and stability of pri and pre-miRNAs (reviewed in Ohman, 2007). 
A-to-I RNA editing by ADARs can block pri-miRNA-142 processing in cell extracts 
and transfected ADAR suppresses mature miRNA-142 expression. Further, 
expression of mature miRNA-142 was increased in ADAR null mice. Cleavage of 
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edited pri-miRNA-142 by Tudor-SN in vitro might explain that no cellular 
accumulation of edited pri-miRNA-142 could be detected (Yang et al., 2006). 
Our goal was to study the impact of RNA editing on miRNA processing and stability 
by directly following the path of pri-miRNA-142 maturation in vivo. Therefore, several 
editing variants of pri-miRNA-142 containing an upstream T7 promoter sequence 
were cloned and in vitro transcribed using T7 RNA Polymerase in the presence of  
[α-32P]ATP. To evaluate processing levels and stability of the pri-miRNA-142 editing 
variants in vivo we performed RNA microinjection experiments in Xenopus eggs and 
analyzed them on PAA-Gels. 
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Results 
Processing and stability of microinjected miRNAs in Xenopus 
laevis oocytes and eggs 
Pre-miRNAs are exported and processed to mature miRNAs in oocytes 
Previous work in Xenopus oocytes revealed that nuclear injected pre-miRNAs are 
exported to the cytoplasm (Lund et al., 2004). Moreover cytoplasmatically injected 
pre-miRNAs are processed to mature microRNAs by Dicer (Lund and Dahlberg, 
2006).  
 
 
Figure 8. Hairpin structure of pre-miRNA-21 
The sequence of pre-miRNA-21 is from miRBASE http://www.mirbase.org 
 
Analysis of nuclear microinjection experiments of ubiquitous pre-miRNA-21 (Figure 8) 
in oocytes confirmed an efficient export to the cytoplasm and subsequent processing 
to mature miRNA (see Figure 9). This is in agreement with other work published 
earlier (Lund et al., 2004). 
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Figure 9. Nuclear injection of pre-miRNAs are exported to the cytoplasm and 
processed to mature microRNAs 
Stage VI oocytes were coinjected with pre-miRNA-21 and U3 snoRNA and incubated for 2 
hours. RNA extraction of nuclei (left) and cytoplasm’s (right) reveals pre-miRNA export and 
processing to the cytoplasm while U3 snoRNA remains stable. 
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Processing of pre-miRNAs in the cytoplasm is enhanced in eggs 
In 2006, Lund & Dahlberg documented enhanced processing of pre-miRNAs in eggs 
compared to oocytes. In order to recapitulate this experiment we used our 
established microinjection system. We were able to confirm an increase in Dicer 
processing upon maturation in a comparative assay (shown in Figure 10).  
 
 
 
Figure 10. Cytoplasmic injections of pre-miRNAs are processed to mature miRNA 
Stage VI oocytes (left) and eggs (right) were injected with pre-miRNA-21 and incubated for 
1h. Gel electrophoresis of extracted RNA shows enhanced processing to mature miRNA. 
 
In summary, nuclear injections of pre-miRNAs in oocytes showed export to the 
cytoplasm and subsequent cleavage by Dicer. When directly injected in the 
cytoplasm of oocytes and eggs a boost of Dicer activity was observed upon 
maturation. These results are consistent with work published earlier (Lund et al., 
2004, Lund and Dahlberg, 2006). 
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Degradation of pri-miRNAs in oocyte germinal vesicle 
To study the efficacy of Drosha mediated cleavage and to study possible differences 
arising by RNA editing, we examined the fate of pri-miRNAs in the oocyte germinal 
vesicle. In somatic cells, pri-miRNAs are cleaved by Drosha in the nucleus, exported 
to the cytoplasm and processed by Dicer. 
 
 
Figure 11. Hairpin structure and flanking region of pri-miRNA-21 
The sequence of pri-miRNA-21 is from miRBASE http://www.mirbase.org 
 
 
To test for Drosha activity we performed nuclear microinjection experiments using 
ubiquitous pri-miRNA-21 (Figure 11) in the oocyte germinal vesicle. Interestingly, no 
Drosha cleavage but degradation by an unknown factor was observed in the 
Xenopus germinal vesicle (see Figure 12). 
In addition, misinjections of pri-miRNAs into the cytoplasm (not shown) appeared to 
leave the pri-miRNAs stable in this cellular compartment. 
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Figure 12. Nuclear injection of pri-miRNAs leads to degradation 
Pri-miRNA-21 and nuclear retained U3 snoRNA were coinjected in stage VI oocytes and 
incubated for up to 4 hours. RNA extraction of nuclei (left) and cytoplasms (right) indicates 
degradation while U3 snoRNA remains in the nucleus. 
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Processing of pri-miRNAs is activated in eggs 
With the finding, that pri-miRNAs remain stable in the oocyte cytoplasm and are 
degraded in the germinal vesicle (Figure 10) we turned our focus on studying the 
efficiency of Drosha mediated cleavage in eggs. Since it was shown that Dicer 
activity is stimulated by oocyte maturation we wondered whether the same would be 
true for Drosha activity. Therefore, to test this possibility we matured stage VI 
oocytes to eggs by the addition of progesterone. Maturation to eggs leads to 
germinal vesicle breakdown (GVBD) and therefore only cytoplasmic injections could 
be performed. 
As depicted in Figure 13, microinjection experiments of ubiquitous pri-miRNA-21 
(Figure 11) clearly showed activation of Drosha mediated processing to pre-miRNA-
21 in eggs. 
 
Figure 13. Injection of pri-miRNAs in eggs leads to processing to pre-miRNAs 
Upon maturation to eggs pri-miRNA-21 was microinjected and incubated for up to 4 hours. 
RNA was extracted and analyzed on a PAA-Gel showing an activation of pri-miRNA-21 
processing to pre-miRNA-21 in eggs. 
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Comparison of pri-miRNA processing in oocyte and egg cytoplasm 
To comparatively investigate the different processing pattern of pri-miRNAs in 
oocytes and eggs, injection experiments were carried out simultaneously in both cell 
types. 
Therefore, both pri-miRNA-21 and the stem cell specific pri-miRNA-29b-1 were 
injected in the cytoplasm of stage VI oocytes and eggs and incubated for up to 4 
hours. 
As shown in Figure 14, this comparative assay confirms that pri-miRNAs are stable in 
the oocyte cytoplasm but get processed in eggs. 
  
Figure 14. Comparison of microinjected pri-miRNAs in eggs and oocytes 
Microinjected pri-miRNA-21 (A) and pri-miRNA-29b-1 (B) in oocytes (left) and eggs (right) were 
incubated for up to 4 hours. RNA extraction and analysis of this comparative assay clearly 
demonstrates the activation of pri-miRNA processing in eggs. 
 
These results confirm the nuclear export and subsequent Dicer processing of 
pre-miRNAs in Xenopus oocytes published earlier (Lund et al., 2004, Lund and 
Dahlberg, 2006). Additionally, activation of pri-miRNA processing was detected in 
Xenopus eggs, whereas pri-miRNAs are degraded in the nucleus and stable in the 
cytoplasmic compartment of Xenopus oocytes. 
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Confirmation of successful processing by miRNA cloning and sequencing 
To confirm successful Drosha processing of pri-miRNAs to pre-miRNAs in Xenopus 
eggs, the obtained putative pre-miRNA band was cut out and eluted. After ligation of 
a 3’- and 5’-Adapter to the putative pre-miRNA molecule RT-PCR was performed. 
The resulting cDNA was cloned into a pGEM-T easy™ Vector and sequenced. 
To avoid contamination with endogenous pre-miRNA molecules human pri-miRNA-
29b-1 was used for microinjection. The resulting pre-miRNA has no homologue in 
Xenopus. Sequence analysis, shown in Figure 15, confirmed appropriate processing 
of microinjected pri-miRNA-29b-1 to pre-miRNA-29b-1 in Xenopus eggs.  
 
Figure 15. Confirmation of appropriate Drosha cleavage 
Sequence analysis was performed using the RT-PCR primer MJ2437 and subsequent PCR 
primer pair MJ2436 and MJ2437. Sequence alignment of cloned putative pre-miRNA-29b-1 
(yellow) with miRBASE annotated pre-miRNA-29b-1 (blue) revealed proper Drosha 
processing of microinjected pri-miRNA-29b-1 in Xenopus eggs. 
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Endogenous Xenopus microRNA processing is enhanced in eggs 
Since oocyte maturation to eggs boosts the processing of injected pre-miRNAs and 
activated processing of pri-miRNAs, we were raising the question if endogenous 
miRNA levels are also affected by the process of maturation. Thus, Northern Blot 
experiments to compare endogenous levels of miRNAs known to be expressed in 
oocytes were carried out. We selected two miRNAs that were shown to be expressed 
in Xenopus germline cells: xtr-miRNA-101 and xtr-miRNA-148a (Armisen et al., 
2009) 
Probes of xtr-miRNA-101 and xtr-miRNA-148a on Northern blots reveal that 
endogenous miRNA processing is enhanced in eggs (see Figure 16 and Figure 17) 
 
Figure 16. Northern Blot of endogenous miRNA-101 and miRNA-148a 
An equal amount of oocyte and egg total RNA (35 cells, equal RNA amount confirmed by 
RiboGreen™ Fluorometric quantification) was separated on a PAA-Gel, semi-dry blotted 
and probed with labeled antisense DNA oligo probes. 
(A) Expression of xtr-miRNA-101 and 
(B) Expression of xtr-miRNA-148a in oocytes and eggs. 
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Dissecting the processing pattern of Xenopus microRNA-148a 
Processing pattern of xtr-pri-miRNA-148a in eggs 
To answer the question to which extent enhanced processing of the endogenous xtr-
miRNA 148a in eggs is regulated by Drosha and Dicer, we cloned and in vitro 
transcribed [α-32P]ATP body labeled Xenopus xtr-pre- and xtr-pri-miRNA-148a. This 
approach allows us to track all steps of miRNA-148a processing during maturation. 
Comparable microinjections of xtr-pri-miRNA-148a in oocytes and eggs clearly 
demonstrate the activation of Drosha processing in eggs (Figure 18). Further, the 
resulting xtr-pre-miRNA-148a is cleaved by Dicer. 
 
 
Figure 18. Processing of pri-xtr-miRNA-148a is activated in eggs 
Comparable microinjections of pri-xtr-miRNA-148a in oocytes and eggs were performed. 
After incubation for 1h efficient Drosha and Dicer cleavage in eggs (right) could be detected. 
In oocytes (left) pri-miRNA-148a remains stable in the cytoplasm. 
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Processing pattern of xtr-pri-miRNA-148a in oocytes 
We further analyzed the processing pattern of xtr-miRNA-148a precursors in oocytes 
performing nuclear injections. Degradation by an unknown factor is detected for pri-
miRNA-148a (as detected for pri-miRNA-21). No processing or export to the 
cytoplasm was detectable while the nuclear retention and stability control U6 snRNA 
remains stable in the nucleus (Figure 20). 
 
 
 
Figure 20. Nuclear injected pri-xtr-miRNA-148a is degraded in the nucleus 
Oocyte nuclear (left) microinjection of pri-xtr-miRNA-148a together with U6 snRNA indicates 
degradation of the pri-miRNA by an unknown factor, whereas U6 snRNA remains stable in 
the nucleus. 
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Processing pattern of xtr-pre-miRNA-148a in oocytes and eggs 
After having shown that pri-miRNAs are unstable in nuclei of Xenopus oocytes, we 
wanted to analyze the fate of nuclear injected pre-miRNAs. To turn our focus on 
differences in Dicer meditated processing we performed microinjection experiments 
using xtr-pre-miRNA-148a. 
Nuclear microinjection showed export and subsequent processing by Dicer in the 
cytoplasm (see Figure 21). 
 
 
Figure 21. Nuclear injection of pre-miRNA-148a shows export and processing 
Nuclear microinjected pre-xtr-miRNA-148a and the nuclear retention control U6 snRNA 
were incubated for 1h and extracted using Trizol reagent. Analysis on a PAA-Gel revealed 
successful export to the cytoplasm and processing by Dicer. 
 
Previous studies had shown a marked increase of Dicer activity upon oocyte 
maturation (Lund and Dahlberg, 2006). We were therefore investigating comparative 
Dicer processing activity in oocytes and eggs by injecting pre-miRNA 148a in both 
cell types (Figure 22). 
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Figure 23 shows a comparative analysis of relative pri- to pre-miRNA-148a 
processing based on absolute intensities in oocytes and eggs. An almost four-fold 
boost of Dicer activity in eggs can be detected upon maturation. 
In summary, these experiments show that the increase in endogenous miRNA-148a 
levels in eggs depends on the activation of Drosha as the rate limiting step and 
additionally on an increased activity of Dicer.  
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Regulation of Drosha activity 
Oocyte maturation leads to activation of pri-miRNA processing in eggs. This result 
raises the questions how Drosha processing is activated in this developmentally 
regulated manner. Therefore, we turned our focus on the regulation of the key 
enzyme Drosha. 
Detection of processing in transcriptionally silent cells 
To check for transcriptional regulation of Drosha activity, eggs were pre-treated with 
the transcriptional inhibitor Actinomycin D (AMD). Consequently, the processing 
pattern of microinjected pri-miRNA-29b-1 (stem cell specific) was examined in the 
AMD treated cells and untreated cells as a control. 
As shown in Figure 24, comparable analysis of AMD treated (A) and untreated cells 
(B) do not show a block of Drosha processing in transcriptionally silent cells. 
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Figure 24. Processing of pri-miRNAs can still be detected in transcriptionally silent 
cells 
Oocytes were pre-incubated with 10μg/ml Actinomycin D and then matured to eggs by 
adding 20μg/ml progesterone. Eggs were injected with pri-miRNA-29b-1, incubated for 2h 
and processing was analyzed on a PAA-Gel. Processing activity could be detected in the 
transcriptionally silent cells (A) comparable to AMD untreated control cells (B). 
 
Additionally, tests using the translational inhibitor Cycloheximide (250μg/ml) were 
performed while initiating maturation. We observed a block of maturation confirming 
previous work that protein synthesis is strictly required for oocyte maturation 
(Wasserman and Masui, 1975, Schuetz and Samson, 1979). 
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Analysis of recombinant Drosha activity in Xenopus oocytes and eggs 
In order to study the activity of Drosha during oocyte maturation at the protein level, 
an amino-terminally 7xmyc-tagged recombinant Xenopus Drosha enzyme (N7myc-
Drosha) was cloned. N7myc-Drosha RNA contains a start-codon and the 3' 
untranslated region of the Xenopus NO38 cDNA harboring a poly(A)+ tail to stabilize 
injected RNAs (Peculis and Gall, 1992). Translation of stored maternal mRNAs is 
controlled by the length of the poly(A) tail. Elongation of poly(A) mediated by CPEB 
facilitates translation of dormant mRNAs during oocyte development (reviewed in 
Mendez and Richter, 2001). 
To examine the regulation of Drosha activity in oocytes and eggs N7myc-Drosha was 
microinjected in oocytes and half of the cells were then matured to eggs. Cleavage 
was examined in immunopreciptation (IP) and subsequent pri-miRNA in vitro 
processing assays using cell extracts of oocytes and eggs. 
As displayed in Figure 25, cells expressing recombinant Drosha establish a distinct 
processing pattern while uninjected control cells do not show processing activity in 
vitro. 
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 Figure 25. Drosha cleavage assay using immunoprecipitated myc-tagged Drosha is 
active in oocytes and eggs 
N7myc-Drosha RNA was injected in oocytes and half of the cells were matured to eggs. 
Immunoprecipitation was performed using α-myc antibody. The pri-miRNA-29b-1 in vitro 
processing assay reveals activity of recombinant Drosha enzyme in oocytes and eggs The 
asterisk indicates the band for pre-miRNA-29b-1. 
 
To further check for differences in pri- to pre-miRNA-29b-1 in vitro processing levels, 
absolute intensities were quantified and relative processing rates were calculated. No 
differences in Drosha activity could be detected in oocytes and eggs expressing 
recombinant Drosha compared to eggs not expressing recombinant Drosha (see 
Figure 26). 
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Figure 26. Quantification of pri- to pre-miRNA-29b-1 processing in oocytes and 
expressing recombinant Drosha 
Immunoprecipitated recombinant Drosha in vitro pri- to pre-miRNA-29b-1 processing rates 
were calculated based on absolute intensities using Bio-Rad™ QuantityOne software. 
Oocytes (column 1) and eggs (column 2) expressing recombinant Drosha do not differ in 
processing levels. Control oocytes (column 3) and eggs (column 4) expressing no 
recombinant Drosha do not exhibit a distinct processing pattern. 
 
Immunoprecipitation and subsequent in vitro processing assays of recombinant 
Drosha expression reveal comparable levels of pri- to pre-miRNA-29b-1 processing 
and no block or inhibition of Drosha activity in oocytes. 
To test for possible inhibitory cofactors that regulate Drosha activity in vivo, 
recombinant Drosha enzyme was expressed in oocytes and half of the cells were 
then matured to eggs. Microinjected pri- to pre-miRNA-29b-1 processing pattern was 
analyzed on a PAA-Gel in Figure 27. It is obvious that recombinant Drosha is active 
in oocytes in vivo (Figure 27B). This in turn suggests that no inhibitor of Drosha 
activity is present in oocytes. 
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Figure 27. Expression of recombinant myc-tagged Drosha in oocytes and eggs 
reveals processing activity in oocytes 
Oocytes were either uninjected (A) or microinjected with N7myc-Drosha RNA (B) and then 
partly matured to eggs. Consequently, oocytes and eggs were microinjected with pri-
miRNA-29b-1 , incubated for 1h and analyzed on a 10%-29:1 AA:bisAA Gel. Recombinant 
Drosha protein is active in Xenopus oocytes. The asterisks mark the expression of 
recombinant Drosha examined by Western blotting. 
 
Taken together, these experiments confirm recombinant Drosha in vitro and in vivo 
activity in stage VI oocyte extracts and stage VI oocytes. We were not able to detect 
a general block or inhibition of enzymatic Drosha activity at this stage of 
development. Thus, expression of recombinant Xenopus Drosha in stage VI oocytes 
is sufficient to regain pri- to pre-miRNA processing activity. 
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Impact of RNA editing on pri-miRNA processing in vivo 
ADAR enzymes, the mediators of A-to-I RNA editing, were originally discovered in 
Xenopus laevis eggs and embryos as an unwinding activity and soon after as a 
dsRNA adenosine deaminase (Bass and Weintraub, 1987, Rebagliati and Melton, 
1987, Bass and Weintraub, 1988, Wagner et al., 1989). Further, the riboncuclease 
Tudor-SN, specifically targeting hyper-edited dsRNA, was shown to be active in 
Xenopus laevis oocyte extracts (Scadden and Smith, 2001b, Scadden, 2005). 
RNA editing of pri- and pre-miRNAs can significantly alter miRNA processing 
patterns or silencing targets. As previously shown, RNA editing at position +4 and +5 
is both, necessary and sufficient, to block pri-miRNA-142 processing in vitro (Yang et 
al., 2006, Kawahara et al., 2007a, Kawahara et al., 2007b). 
Activation of pri-miRNA processing in Xenopus eggs provides an excellent tool to 
investigate the effects of RNA editing on Drosha processing in vivo. Several editing 
variants of pri-miRNA-142 containing an upstream T7 promoter sequence were 
cloned and in vitro transcribed using T7 RNA Polymerase. To evaluate processing 
levels of the pri-miRNA-142 editing variants, RNA microinjection experiments in eggs 
were performed and analyzed on PAA-Gels. 
We analyzed the effect of RNA editing on Drosha mediated processing in vivo, using 
wild-type pri-miRNA-142 (Figure 28A) and further designed a pre-edited clone 
mimicking A-to-I editing by the introduction of G at position +4 and +5 (Figure 28B). 
Introduction of structural alterations, by using guanosine instead of inosine in the pre-
edited variant, is assumed to be equivalent to those of the A-to-I edited pri-miRNA 
142. We anticipated for the pre-edited variant that replacing A-U Watson-Crick pairs 
at position +4 and +5 with G●U wobble pairs (instead of two isosteric I●U wobble 
pairs) is equivalent to those of the A-to-I edited pri-miRNA-142 (Yang et al., 2006, 
Masquida and Westhof, 2000). A mutation, that precludes RNA editing, was 
introduced as an editing control by replacing A with C at position +4, +5 and +6 and 
U with C as their counterparts (Figure 28C). Further, a compensatory mutation was 
established, having A exchanged with G at position +4, +5 and +6 and U with G as 
their counterparts in the hairpin (Figure 28D). 
 
Results 
57 
 
Figure 28. Variants of pri-miRNA-142 used in processing analysis 
(A) pri-miRNA-142 : sequence annotated on www.mIRbase.org 
(B) pri-miRNA-142 : pre-edited: A-to-G at position +4,+5 
(C) pri-miRNA-142 : degenerated CCC: A-to-C at position +4,+5,+6 (mutated editing 
site) 
(D) pri-miRNA-142 : degenerated GGG: A-to-G at position +4,+5,+6 (compensatory 
mutated editing site) 
 
T7 RNA Polymerase mediated in vitro transcription of pri-miRNA-142 variants was 
performed in the presence of [α-32P]ATP. Equal amounts of the body-labeled pri-
miRNA-142 variants were microinjected and the processing rates were analyzed on 
PAA-Gels (see Figure 29). 
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Figure 29. Processing of pri-miRNA-142 variants in Xenopus eggs 
Microinjection of (A) pri-miRNA-142, (B) pri-miRNA-142 pre-edited, (C) pri-miRNA-142 
degenerated CCC and (D) pri-miRNA-142 degenerated GGG in eggs. After an incubation of 
0.5h the extracted RNA was analyzed on a 10% PAA-Gel. 
 
Further, pri- to pre-miRNA-142 processing rates depending on absolute intensities 
were calculated. As displayed in Figure 30, in contrast to the wild type and the control 
variants the pre-edited pri-miRNA-142 processing level is strongly reduced in vivo. 
Cloning and sequence analysis of microinjected pri-miRNA-142 variants did not 
reveal de novo A-to-I RNA editing in eggs. Hence, pri-miRNA-142 variants remain 
stable and are not targeted by Tudor-SN which degrades hyperedited RNA 
molecules (Scadden, 2005). 
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Figure 30. Processing of pre-edited pri-miRNA-142 is reduced in vivo 
Processing levels of pri-miRNA-142 variants were calculated from absolute intensities using 
Bio-Rad™ QuantityOne software. A dramatic drop in processing for the pre-edited variant of 
pri-miRNA-142 can be detected. 
 
In summary, this comparative assay reveals a striking reduction of pre-miRNA-142 
levels in vivo only for pre-edited pri-miRNA 142. The wild-type and control pri-miRNA-
142 variants exhibit comparable processing rates. Moreover, no de novo A-to-I RNA 
editing of pri-miRNA-142 could be detected leaving the pri-miRNA-142 variants 
stable in the Xenopus eggs.  
Discussion 
60 
Discussion 
Gene regulation by miRNAs plays an important role in the development and 
differentiation of animals (reviewed in Bushati and Cohen, 2007). Biogenesis of 
miRNAs can be controlled by the regulation of miRNA gene transcription, by post-
transcriptional modification of miRNA maturation and post-translational regulation of 
the key enzymes Drosha and Dicer influencing the processing of miRNA precursors 
(reviewed in Krol et al., 2010). 
The maturation of Xenopus oocytes to eggs is accompanied by a cessation of 
transcription and a complex network of translational activation and repression of 
stored maternal mRNAs (reviewed in Mendez and Richter, 2001). Recently it became 
clear that oocyte maturation can boost Dicer activity and that miRNAs are expressed 
in a stage specific manner in Xenopus development (Lund and Dahlberg, 2006, 
Watanabe et al., 2005, Lund et al., 2009, Armisen et al., 2009). 
In order to gain insight in the regulation of miRNA maturation in Xenopus oogenesis 
we created a miRNA precursor microinjection system in Xenopus stage VI oocytes 
and eggs. Evaluating the processing pattern of the pre- and pri-miRNAs allowed us 
to track all steps in miRNA biogenesis during the maturation from oocytes to eggs. 
 
Developmental activation of pri-miRNA processing 
Data from microinjection experiments in oocytes confirmed previous work that pre-
miRNAs are exported from the nucleus and processed by Dicer in the cytoplasm 
(Lund et al., 2004). Consequently, comparative analysis of Dicer cleavage also 
revealed enhanced processing in eggs as described earlier (Lund and Dahlberg, 
2006). 
We were able to provide new insight that pri-miRNA processing is activated upon 
maturation to eggs. Further, pri-miRNAs are degraded by an unknown factor in the 
germinal vesicle of stage VI oocytes. G2 arrested stage VI oocytes are 
transcriptionally inactive, which does not rule out that miRNA gene transcription and 
processing occurs earlier in development. However, in contrast to somatic cells, 
oocytes at this stage of development obviously do not have active nuclear Drosha. 
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Further, microinjection experiments into the cytoplasm of oocytes could show that pri-
miRNAs remain stable in this cellular compartment. Additionally, comparative 
experimental evidence in both cell types could clearly demonstrate the activation of 
pri-miRNA processing in eggs. In Northern Blot experiments the biological 
importance of the Drosha activation could be confirmed by showing a strong increase 
of endogenous xtr-miRNA-101 and xtr-miRNA-148a upon maturation. However, we 
cannot distinguish if pri-miRNA transcription levels are also elevated or if pri-miRNAs 
already present in the oocyte are processed upon maturation. Enhanced 
endogenous miRNA levels could also be explained by processing of pre-miRNAs 
stored in the cytoplasm. This is rather unlikely, because Dicer is also active in stage 
VI oocytes, a stage lasting for several months. 
Taken together, these facts might argue for a possible storage of (maternal) pri-
miRNA molecules in the cytoplasm as observed for maternal mRNAs. Maternally 
inherited mRNAs are stored during the long period of oogenesis and remain dormant 
in oocytes. One important startpoint for mobilizing the stored mRNA is maturation, 
when several cell-cycle-control proteins are starting to be translated (reviewed in 
Radford et al., 2008). However, so far no experimental evidence has documented 
storage of miRNA precursor molecules in oocytes. 
To further asses the distinct processing pattern of Xenopus miRNA precursors we 
performed microinjection experiments using xtr-pri- and xtr-pre-miRNA-148a. 
Comparison of pri-miRNA-148a Drosha processing rates in oocytes and eggs 
revealed a complete activation of processing upon maturation to eggs. This result 
goes in line with the activation of pri-miRNA processing demonstrated in earlier 
experiments. In contrast to Drosha activation, xtr-pre-miRNA-148a Dicer processing 
can already be detected in stage VI oocytes. Maturation then intensifies xtr-pre-
miRNA-148a Dicer processing up to four times. 
On the whole these results demonstrate a developmentally regulated onset of 
Drosha and increase of Dicer activity leading to enhanced of miRNA biogenesis. 
Accordingly, Drosha processing is the rate limiting step in enhancing mature xtr-
miRNA-148a levels during maturation. This potentially has important implications on 
miRNA mediated gene regulation during oogenesis and fertilization. Previous work 
showed that miRNAs play an important role in the turnover of maternal mRNAs 
during the switch from maternal to zygotic gene expression by mediating 
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deadenylation of target mRNAs (Giraldez et al., 2006, Bushati et al., 2008). Thus, the 
function of the miRNA upregulation and which targets are affected in eggs have to be 
elucidated. 
Developmental regulation of Drosha activity 
Stage VI oocytes are assumed to be transcriptionally inactive (reviewed in Mendez 
and Richter, 2001). However, to investigate a possible activation of Drosha RNA 
transcription upon maturation we applied the transcriptional inhibitor Actinomycin D 
(AMD). Microinjection of pri-miRNAs in eggs matured in the presence of AMD 
showed no differences in pri-miRNA Drosha processing. We therefore conclude that 
Drosha activity is not influenced by transcription during maturation. 
We examined post-translational regulation as another possible regulator of Drosha 
activity in eggs. Therefore evaluation of Drosha regulation at the protein level by in 
vitro processing experiments using immunoprecipitated recombinant Xenopus 
Drosha revealed no differences of activity when recombinantly expressed in oocytes 
and matured to eggs. This approach does not rule out the possibility that Drosha 
might be regulated by potential interaction partners or inhibitors in vivo. 
Consequently, tests for inhibitory cofactors that regulate Drosha activity in vivo using 
recombinant protein were carried out. Microinjection experiments using pri-miRNA in 
oocytes and eggs that express recombinant Drosha showed Drosha activity in both 
cell types. Thus, Drosha protein is not blocked or inhibited in stage VI oocytes. 
Additional tests on Drosha regulation at the protein level were performed using the 
translational inhibitor Cycloheximide while initiating maturation. We observed a block 
of maturation confirming previous work showing that protein synthesis is strictly 
required for oocyte maturation (Wasserman and Masui, 1975, Schuetz and Samson, 
1979). 
In summary, these experiments demonstrate that no post-translational blockage or 
inhibitory cofactors of Drosha could be identified in stage VI oocytes. Hence, 
expression of recombinant Drosha is sufficient to regain pri-miRNA processing 
activity in stage VI oocytes. However, we cannot exclude that a post-translational 
inhibition or modification, leading to inactivation of Drosha enzyme, occurs earlier in 
development. 
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Another approach evaluating developmental regulation of Drosha is investigating an 
important factor modulating translation of mRNAs in the developing oocyte. CPEB, a 
highly conserved, sequence-specific RNA binding protein targeting the cytoplasmic 
polyadenylation element, regulates mRNA translation by cytoplasmic polyadenylation 
of mRNAs (reviewed in Mendez and Richter, 2001). Induction of translation in early 
development by polyadenylation seems to be a characteristic of all metazoans (Fox 
et al., 1989, McGrew et al., 1989, Tay et al., 2000, Minshall et al., 1999, Gebauer et 
al., 1994, Salles et al., 1994). 
In order to investigate cytoplasmic polyadenylation regulating the translation of 
Drosha, we are performing experiments comparing the length of Drosha mRNAs in 
the process of maturation. Further, tests studying translational regulation of Drosha 
activity are performed using RNase H and morpholino assays to perturb Drosha RNA 
levels. These experiments are still pending and will be presented elsewhere. 
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Impact of RNA editing on pri-miRNA processing in vivo 
ADAR proteins and proteins of the RNAi machinery, such as the microprocessor 
complex (Drosha-DGCR8), Dicer and TRBP contain dsRBDs. In general, there is no 
sequence specificity for dsRBDs which makes these proteins potential competitors 
for RNA binding (Saunders and Barber, 2003, reviewed in Nishikura, 2006). 
Moreover, extensively A-to-I edited dsRNA in vitro by ADAR generates less siRNA 
and reduced RNAi (Scadden and Smith, 2001a). The double-stranded hairpin of 
miRNA precursors are common targets of ADAR1 and ADAR2 (Luciano et al., 2004, 
Blow et al., 2006, Calin and Croce, 2006). Recent studies detected RNA editing of 
several adenosine residues of pri-miRNA 142. In vitro experiments using 
Drosha/DGCR8 complexes revealed that editing of position +4 and +5 located in the 
fold-back dsRNA stem near the Drosha cleavage site is both, necessary and 
sufficient, to inhibit Drosha cleavage (Yang et al., 2006). 
In order to gain insight into the effects of RNA editing on pri-miRNA-142 processing 
in vivo, we investigated different editing variants of pri-miRNA-142 using our 
established Xenopus eggs microinjection system. 
We analyzed four different variants of pri-miRNA 142: a wild-type variant, a pre-
edited pri-miRNA (A-to-G at position +4, +5), a mutated variant that precludes editing 
as well as a compensatory mutated variant. In the pre-edited variant two A-U 
Watson-Crick pairs at position +4 and +5 were replaced with G●U wobble pairs 
instead of two isosteric I●U wobble pairs (Yang et al., 2006, Masquida and Westhof, 
2000). 
When compared to wild-type and control variants processing of the pre-edited pri-
miRNA-142 is strikingly reduced in vivo. Reduction in processing levels might be 
explained by the introduced structural change in the hairpin of the pre-edited pri-
miRNA-142 variant. This could lead to a reduced DGCR8 binding and/or subsequent 
Drosha cleavage. Further, it cannot be excluded that the pre-edited pri-miRNA 
variant is a prevalent dsRNA target for ADAR enzyme. The dsRBDs harboring 
proteins DGCR8 and ADAR are putative competitors for binding the double-stranded 
hairpin. Enhanced ADAR binding would have an antagonistic effect on processing by 
the microprocessor complex. Additional experiments elucidating the role of 
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competitive dsRNA binding will provide further insight the reduction of edited pri-
miRNA-142 processing in vivo. 
Another important finding is high stability of pri-miRNA-142 upon microinjection in the 
egg. Sequencing of microinjected pri-miRNA-142 could not show de novo RNA 
editing in vivo leaving unprocessed pri-miRNA-142 stable in the egg. This result is in 
contrast to previous work where unprocessed pri-miRNA-142 was A-to-I edited and 
therefore a potential target for degradation by Tudor-SN (Yang et al., 2006, Scadden, 
2005). 
However, reduced processing of pre-edited pri-miRNA-142 in vivo goes in hand with 
results published for inhibition of pri-miRNA-142 processing in vitro and pre-miRNA-
151 in vivo processing (Yang et al., 2006, Kawahara et al., 2007a). This further 
proves the importance of RNA editing as an antagonist of miRNA biogenesis and 
consequently miRNA mediated gene silencing. 
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